Human Filamin-A(FLNA) ELISA kit

Instructions
Code CSB-EL008724HU
Size 96T,5×96T,10×96T
Trial Size 24T ELISA kits trial application
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Target Name filamin A, alpha (actin binding protein 280)
Alternative Names ABP 280 ELISA Kit; ABP-280 ELISA Kit; Actin-binding protein 280 ELISA Kit; Alpha filamin ELISA Kit; Alpha-filamin ELISA Kit; APBX ELISA Kit; CSBS ELISA Kit; CVD1 ELISA Kit; Endothelial actin binding protein ELISA Kit; Endothelial actin-binding protein ELISA Kit; Filamin 1 ELISA Kit; Filamin A alpha ELISA Kit; Filamin A ELISA Kit; Filamin-1 ELISA Kit; Filamin-A ELISA Kit; FLN ELISA Kit; FLN-A ELISA Kit; FLN1 ELISA Kit; FLNA ELISA Kit; FLNA_HUMAN ELISA Kit; FMD ELISA Kit; MNS ELISA Kit; NHBP ELISA Kit; Non muscle filamin ELISA Kit; Non-muscle filamin ELISA Kit; OPD ELISA Kit; OPD1 ELISA Kit; OPD2 ELISA Kit; XLVD ELISA Kit; XMVD ELISA Kit
Abbreviation FLNA
Uniprot No. P21333
Species Homo sapiens (Human)
Sample Types serum, plasma, tissue homogenates, cell lysates
Detection Range 18.75 pg/mL-1200 pg/mL
Sensitivity 4.68 pg/mL
Assay Time 1-5h
Sample Volume 50-100ul
Detection Wavelength 450 nm
Research Area Signal Transduction
Assay Principle quantitative
Measurement Sandwich
Precision
Intra-assay Precision (Precision within an assay): CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess.
Inter-assay Precision (Precision between assays): CV%<10%
Three samples of known concentration were tested in twenty assays to assess.
Linearity
To assess the linearity of the assay, samples were spiked with high concentrations of human FLNA in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
 SampleSerum(n=4)
1:5Average %95
Range %91-104
1:10Average %89
Range %87-93
1:20Average %98
Range %93-102
1:40Average %90
Range %87-94
Recovery
The recovery of human FLNA spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
Sample TypeAverage % RecoveryRange
Serum (n=5) 9692-101
EDTA plasma (n=4)9890-104
Typical Data
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
pg/mlOD1OD2AverageCorrected
12002.592 2.492 2.542 2.401
6002.012 1.912 1.962 1.821
3001.383 1.283 1.333 1.192
1500.729 0.719 0.724 0.583
750.436 0.426 0.431 0.290
37.50.344 0.334 0.339 0.198
18.750.228 0.218 0.223 0.082
00.142 0.140 0.141  
Troubleshooting
and FAQs
ELISA kit FAQs
Storage Store at 2-8°C. Please refer to protocol.
Lead Time 7-14 working days

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Earn $30 Amazon Card or 20μL/μg CUSABIO Trial Size Antibody. Details of rewards >>

 Q&A
Q:

Can you provide me with the information if antibodies are polyclonal or monoclonal?

A:
Thanks for your inquiry!CSB-EL008724HU: Coated anti: Mouse monoclonal antibody Detect anti: Goat polyclonal antibody

Target Background

Function
(From Uniprot)
Promotes orthogonal branching of actin filaments and links actin filaments to membrane glycoproteins. Anchors various transmembrane proteins to the actin cytoskeleton and serves as a scaffold for a wide range of cytoplasmic signaling proteins. Interaction with FLNA may allow neuroblast migration from the ventricular zone into the cortical plate. Tethers cell surface-localized furin, modulates its rate of internalization and directs its intracellular trafficking (By similarity). Involved in ciliogenesis. Plays a role in cell-cell contacts and adherens junctions during the development of blood vessels, heart and brain organs. Plays a role in platelets morphology through interaction with SYK that regulates ITAM- and ITAM-like-containing receptor signaling, resulting in by platelet cytoskeleton organization maintenance (By similarity).
Gene References into Functions
  1. The authors describe a family with a novel FLNA mutation with a male-expressed, apparently isolated, cardiac phenotype with no skewed X-inactivation pattern in female carriers. PMID: 29146485
  2. silencing filamin A may inhibit the invasion and migration of breast cancer cells by upregulating 14-3-3sigma. PMID: 30074213
  3. FLNA overexpression suppressed the proliferation of Bladder Carcinoma cells, blocked cell cycle and promoted apoptosis of Bladder Carcinoma cell. PMID: 29288417
  4. Silencing filamin A (FLNa) expression in lung cancer cell line A549 cells promoted proliferation, migration, and invasiveness of A549 cells by enhancing the activation of epidermal growth factor receptor and ERK signaling pathway. PMID: 29272322
  5. Reduced RNA editing of FLNA gene is associated with psoriasis. PMID: 29592874
  6. Data indicate mutations in FLNA (Filamin A) associated with Ebstein anomaly. PMID: 29237676
  7. these observations describe a new mechanism of tissue-specific regulation of FLNA that could reflect the differing mechanical requirements of these cell types during development. PMID: 29024177
  8. This study also indicates that FLNA may affect white matter integrity in patients with periventricular nodular heterotopia related epilepsy. PMID: 29062687
  9. The mutations of the FLNA gene were observed in 7 (30.4%) of the 23 patients who with Sporadic periventricular nodular heterotopia. PMID: 28411558
  10. Data show that AR-deficient and highly metastatic prostate cancer cell lines express higher levels of filamin A compared to normal prostate epithelial cells and AR-positive and less metastatic prostate cancer. Also, the results identified that Cao2+ via CaR-mediated signaling induces filamin A cleavage and promotes the migration in AR-deficient and highly metastatic prostate cancer cells. PMID: 27206800
  11. FLNA is downregulated in parathyroid tumors and parallels the CASR expression levels. Loss of FLNA reduces CASR mRNA and protein expression levels and the CASR-induced ERK phosphorylation. FLNA is involved in receptor expression, membrane localization and ERK signaling activation of both 990R and 990G CASR variants. PMID: 27872158
  12. We report two brothers carrying a loss-of-function mutation of FNLA with gonadal differentiation disorder and hypospadias. Specific staining for AR shows almost an absolute absence of these receptors in the testicular tissue. PMID: 28432720
  13. Lowering the FLNA level elevated RalA activity and resulted in selective interference with the normal intracellular trafficking and signaling of the D2R and D3R, through GRK2 and beta-arrestins, respectively. FLNA is a multi-functional protein that acts as a platform on which D2R and D3R can interact with various proteins causing selective regulation of these receptors occurs in combination with GRK2 and beta-arrestins. PMID: 27188791
  14. FLNA upregulation correlates with Snail-induced epithelial to mesenchymal transition in colorectal carcinoma. PMID: 28778796
  15. Our findings expand the male-specific phenotype of FLNA mutations that now includes classical-like EDS with lethal cardiac valvular dystrophy, and offer further insights for the genotype-phenotype correlations within this spectrum. PMID: 27739212
  16. Study identifies ANXA4 and FLNA as up-regulated in buccal squamous cell carcinoma arising from oral submucous fibrosis. PMID: 27485544
  17. These results provide new insights into the regulation of SK2 channel trafficking by the cytoskeletal proteins FLNA and alpha-actinin2, involving distinct recycling pathways PMID: 27779751
  18. Respiratory failure secondary to progressive obstructive lung disease during infancy may be the presenting phenotype of FLNA-associated periventricular nodular heterotopia. PMID: 28457522
  19. The actin regulator FLNA interacts with the endoplasmic reticulum stress kinase PERK and this interaction is required for the efficient formation of ER-plasma membrane contact sites. PMID: 28238652
  20. CCR2B and beta2AR signals to FLNa to stimulate its endocytosis and recycling to the plasma membrane. PMID: 27909248
  21. In humans, mutations in the actin-binding protein Filamin-C result in myopathies, but the underlying molecular function is not well understood. Here we show using Drosophila indirect flight muscle that the filamin ortholog Cheerio in conjunction with the giant elastic protein titin plays a crucial role in keeping thin filaments stably anchored at the Z-disc PMID: 28732005
  22. Case Report: Reduced binding of mutant FLNa to beta3 and the facilitated recruitment of talin by beta3 on platelet stimulation, explaining the increased alphaIIbbeta3 activation and the ensuing gain-of-platelet functions. PMID: 28428218
  23. results reveal an unusual structural and thermodynamic basis for the P2204L-induced dysfunction of filamin and frontometaphyseal dysplasia disease. PMID: 28348077
  24. Mechanistic analysis revealed that FLNA suppresses pol III gene transcription by confining the recruitment of the RNA pol III transcription machinery at the promoters of the genes that are sensitive to the alteration of FLNA expression. PMID: 27738102
  25. FlnA more strongly binds RhoA, although both filamins overlap with RhoA expression in the cell cytoplasm. FlnA promotes RhoA activation whereas FlnB indirectly inhibits this pathway. Moreover, FlnA loss leads to diminished expression of b1-integrin, whereas FlnB loss promotes integrin expression PMID: 28175289
  26. FLNA can function as a modulator of chemosensitivity to docetaxel in triple-negative breast cancer (TNBC) cells through regulation of the MAPK/ERK pathway both in vitro and in vivo. FLNA may serve as a novel therapeutic target for improvement of chemotherapy efficacy in TNBC. PMID: 26546439
  27. Results indicate that mTORC2 regulates filamin A-dependent focal adhesions and cell migration. PMID: 27059097
  28. The syndrome affecting the family shares phenotypic overlap with other syndromes caused by FLNA mutations, but appears to be a distinct phenotype, likely representing a unique genetic syndrome. PMID: 26804200
  29. The findings in these cases are distinct from previously described FLNA related disorders by virtue of decreased joint mobility and spontaneous keloid scarring. They occur in association with a novel mutation and represent a novel genetic syndrome. PMID: 26686323
  30. FLNA gene mutation analysis was performed in a series of 10 fetuses and a neonatally deceased newborn displaying a multiple congenital anomalies syndrome suggestive of otopalatodigital spectrum disorders. PMID: 26404489
  31. This study expands the diversity of the phenotypes associated with loss-of-function mutations in FLNA. PMID: 26059841
  32. Filamin-A is required to mediate SSTR2 effects in pancreatic neuroendocrine tumours PMID: 26733502
  33. The function of different integrins is subjected to differential regulation by FLNa. PMID: 26572583
  34. FLNA functions as a positive cellular transducer linking actin polymerization to MKL1-SRF activity, counteracting the known repressive complex of MKL1 and monomeric G-actin. PMID: 26554816
  35. Missense substitutions in FLNA were identified in four unrelated craniosynostosis patients. PMID: 25873011
  36. studies suggest that Vpu hijacks the FLNa function in the modulation of tetherin to neutralize the antiviral factor tetherin. PMID: 26742839
  37. Our interpretation of these contradictions is that truncation and/or mutation of RhoGDI2 perturbs its conformation to expose a site that adventitiously binds FLNA and is not a bona-fide interaction. PMID: 26707877
  38. Extracellular sphingosine-1-phosphate activates NF-kappaB only in melanoma cells that lack FLNA. PMID: 26552704
  39. FLNA anchors PC2 to the actin cytoskeleton through complex PC2-FLNA-actin to reduce degradation and increase stability, and possibly regulate PC2 function in a Ca-dependent manner. PMID: 25861040
  40. These observations imply that other interactions apart from those mediated by the canonical repeat 24 dimerisation interface contribute to FLNA homodimerization and that mutations affecting this region of the protein can have broad phenotypic effects. PMID: 25686753
  41. Our results support FLNA as a new downstream effector of mTORC2 controlling GBM cell motility. PMID: 26134617
  42. Familial periventricular nodular heterotopia, epilepsy and Melnick-Needles Syndrome caused by a single FLNA mutation with combined gain-of-function and loss-of-function effects PMID: 25755106
  43. The data suggest a molecular mechanism for direct G protein-coupled receptors -cytoskeleton coupling via filamin A. PMID: 26460884
  44. Frontometaphyseal dysplasia and keloid formation without normally present in this condition FLNA mutations have been described in six unrelated children patients. PMID: 25899317
  45. FLNA analysis was performed by DHPLC followed by Sanger sequencing [Robertson et al., 2006]. Both sisters were heterozygous for a novel mutation, c.6611C>T in exon 41, that predicts the substitution p.Pro2204Leu within filamin repeat 20 PMID: 25820619
  46. FLNa showed low expression in colorectal adenocarcinoma, high correlation with the incidence and development of colorectal cancer, and was considered an indicator of prognosis. PMID: 25717257
  47. The androgen-triggered AR/filamin A complex controls, through Rac 1, the decision of cells to halt cell cycle and migration. PMID: 25476896
  48. Virus infection and RNase L activation disrupt its association with Filamin A and release RNase L to mediate its canonical nuclease-dependent antiviral activities. PMID: 25352621
  49. Autoinhibited filamin is refractory to phosphorylation by PKA on a known Ser(2152) site despite its consensus motif being exposed and the corresponding isolated peptide being readily phosphorylated. PMID: 25666618
  50. this study proposes that FLNA interaction with ICL3(intracellular loop) is central for endocytosis and signaling of WT and WHIM-like CXCR4 receptors. PMID: 25355818

Show More

Hide All

Involvement in disease Periventricular nodular heterotopia 1 (PVNH1); Otopalatodigital syndrome 1 (OPD1); Otopalatodigital syndrome 2 (OPD2); Frontometaphyseal dysplasia 1 (FMD1); Melnick-Needles syndrome (MNS); Intestinal pseudoobstruction, neuronal, chronic idiopathic, X-linked (IPOX); FG syndrome 2 (FGS2); Terminal osseous dysplasia (TOD); Cardiac valvular dysplasia X-linked (CVDX); Congenital short bowel syndrome, X-linked (CSBSX)
Subcellular Location Cytoplasm, cell cortex, Cytoplasm, cytoskeleton
Protein Families Filamin family
Tissue Specificity Ubiquitous.
Database Links

HGNC: 3754

OMIM: 300017

KEGG: hsa:2316

STRING: 9606.ENSP00000358866

UniGene: Hs.195464

Newsletters

Get all the latest information on Events, Sales and Offers. Sign up for newsletter today.

© 2007-2021 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1